David E. Goldstein

10.7k citations

66 papers · 7.9k indexed · 3 hit papers · h-index 36

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
Clinical Biochemistry top 1%

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 40
- Diabetes Management and Research 31
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 10
Physiology 16
- Diet and metabolism studies 7
- Erythrocyte Function and Pathophysiology 6

Co-authors: Randie R. Little (35 shared papers)Hsiao-Mei Wiedmeyer (25 shared papers)J D England (26 shared papers)Mark S. Eberhardt (2 shared papers)Katherine M. Flegal (2 shared papers)Maureen I Harris (1 shared paper)Danita D. Byrd-Holt (1 shared paper)Catherine C. Cowie (1 shared paper)
Journals: Clinical Chemistry (18 papers)Diabetes Care (14 papers)Diabetes (5 papers)The Journal of Pediatrics (3 papers)Journal of Consulting and Clinical Psychology (2 papers)
Partner nations: United States Sweden India

In The Last Decade

David E. Goldstein

65 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

Defining the Relationship Between Plasma Glucose and HbA1c 2002 · 760 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Diabetes Care
2002 Clinical Chemistry
1998 Diabetes Care

Peers

Countries citing papers authored by David E. Goldstein

Since Specialization

Citations

This map shows the geographic impact of David E. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Goldstein more than expected).

Fields of papers citing papers by David E. Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Goldstein. The network helps show where David E. Goldstein may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Goldstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Goldstein Line = papers co-authored together David E. Goldstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care ·Maureen I Harris, Katherine M. Flegal, Catherine C. Cowie, Mark S. Eberhardt, David E. Goldstein, Randie R. Little, Hsiao-Mei Wiedmeyer, Danita D. Byrd-Holt Hit paper breakdown →	1998	2137
2	Defining the Relationship Between Plasma Glucose and HbA1c Diabetes Care ·Curt L. Rohlfing, Hsiao-Mei Wiedmeyer, Randie R. Little, J D England, Alethea L. Tennill, David E. Goldstein Hit paper breakdown →	2002	760
3	Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus Clinical Chemistry ·David B. Sacks, David E. Bruns, David E. Goldstein, Noel K. Maclaren, Jay M. McDonald, Marian Parrott Hit paper breakdown →	2002	626
4	Tests of Glycemia in Diabetes Diabetes Care ·David E. Goldstein, Randie R. Little, Rodney A. Lorenz, John I. Malone, David Nathan, Charles M. Peterson, David B. Sacks	2004	469
5	Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) The Journal of Pediatrics ·Neil H. White, Patricia A. Cleary, William T. Dahms, David E. Goldstein, James Malone, W. V. Tamborlane, (unknown)	2001	334
6	Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care ·Curt L. Rohlfing, Randie R. Little, Hsiao-Mei Wiedmeyer, J D England, Richard Madsen, Marsha Harris, Katherine M. Flegal, Mark S. Eberhardt, David E. Goldstein	2000	312
7	The national glycohemoglobin standardization program: a five-year progress report. PubMed ·Randie R. Little, Curt L. Rohlfing, Hsiao-Mei Wiedmeyer, Gary L. Myers, David B. Sacks, David E. Goldstein	2001	270
8	Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. The Journal of Immunology ·Daniel U. Rabin, Susan M Pleasic, Jeffrey Shapiro, H Yoo-Warren, J Oles, Jessica Hicks, David E. Goldstein, Peter M. M. Rae	1994	255
9	Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clinical Chemistry ·Dennis Klenk, Greg T. Hermanson, Randall I. Krohn, Edward K. Fujimoto, A. Krishna Mallia, P. K. Smith, J D England, Hsiao-Mei Wiedmeyer, Randie R. Little, David E. Goldstein	1982	218
10	Glycated hemoglobin: methodologies and clinical applications. PubMed ·David E. Goldstein, Randie R. Little, Hsiao-Mei Wiedmeyer, J D England, Edith M McKenzie	1986	199
11	What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry Clinical Chemistry ·Charles M. Peterson, J. Pavlovich, David E. Goldstein, Randie R. Little, J D England	1998	157
12	Improved colorimetric assay for glycosylated hemoglobin. Clinical Chemistry ·Kayla Parker, J D England, Joana Costa, R. Hess, David E. Goldstein	1981	153
13	Biological Variation of Glycohemoglobin Clinical Chemistry ·Curt L. Rohlfing, Hsiao-Mei Wiedmeyer, Randie R. Little, V. Lee Grotz, Alethea L. Tennill, J D England, Richard Madsen, David E. Goldstein	2002	142
14	Tests of Glycemia in Diabetes Diabetes Care ·David E. Goldstein, Randie R. Little, Rodney A. Lorenz, John I. Malone, David M. Nathan, Charles M. Peterson	1995	131
15	Effects of Acute Changes in Blood Glucose on HbA1c Diabetes ·David E. Goldstein, Steven B Peth, J D England, Randall L Hess, Jose Da Costa	1980	121
16	Clinical Application of Glycosylated Hemoglobin Measurements Diabetes ·David E. Goldstein, Kayla Parker, J D England, Jack E England, Hsiao-Mei Wiedmeyer, Sharon S Rawlings, Randall Hess, Randie R. Little, John F. Simonds, Russell P Breyfogle	1982	121
17	Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus Diabetes Care ·David B. Sacks, David E. Bruns, David E. Goldstein, Noel K. Maclaren, Jay M. McDonald, Marian Parrott	2002	96
18	Interlaboratory Standardization of Measurements of Glycohemoglobins Clinical Chemistry ·Randie R. Little, Hsiao-Mei Wiedmeyer, J D England, A L Wilke, Curt L. Rohlfing, Frank H. Wians, Jana Jacobson, V Zellmer, David E. Goldstein	1992	90
19	Relationship of Glycosylated Hemoglobin to Oral Glucose Tolerance: Implications for Diabetes Screening Diabetes ·Randie R. Little, J D England, Hsiao-Mei Wiedmeyer, Edith M McKenzie, David J. Pettitt, William C. Knowler, David E. Goldstein	1988	68
20	Effect of Inhaled Beclomethasone Dipropionate on Hypothalamic-Pituitary-Adrenal Axis Function in Children with Asthma PEDIATRICS ·David E. Goldstein, Peter König	1983	67

About David E. Goldstein

David E. Goldstein is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Genetics, Genetics and Hematology, having authored 66 papers that have together received 7.9k indexed citations. Recurring topics across this work include Diabetes Management and Research (31 papers), Diabetes and associated disorders (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Metabolism, Diabetes, and Cancer (12 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers), Diet and metabolism studies (7 papers), Erythrocyte Function and Pathophysiology (6 papers) and Pancreatic function and diabetes (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.0k citations), Clinical Biochemistry (385 citations), Genetics (1.5k citations), Physiology (1.0k citations) and Pharmacy (170 citations). David E. Goldstein has collaborated with scholars based in United States, Sweden and India. Frequent co-authors include Randie R. Little, Hsiao-Mei Wiedmeyer, J D England, Mark S. Eberhardt, Katherine M. Flegal, Maureen I Harris, Danita D. Byrd-Holt, Catherine C. Cowie, Curt L. Rohlfing and David B. Sacks. Their work appears in journals such as Clinical Chemistry, Diabetes Care, Diabetes, The Journal of Pediatrics and Journal of Consulting and Clinical Psychology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact